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Abstract Phospholipase D was first described in plant tissue
but has recently been shown to occur in mammalian cells where it
is activated by cell surface receptors. Its mode of activation by
receptors in unclear. Biochemical studies suggest that it may
occur downstream of other effector proteins and that small GTP-
dependent regulatory proteins may be involved. The sequence in a
non-designated region of mammalian phospholipase D1 and 2
shows similarity to a structural domain that is present in
signalling proteins that are regulated by protein kinases or
heterotrimeric G-proteins. Mammalian phospholipase D has
structural similarities with other lipid signalling phospholipases
and thus may be regulated by receptors in an analogous fashion.
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1. Introduction
Mammalian phospholipase (PL)D is activated in a wide
variety of cells by receptor subtypes that also regulate in-
creases in intracellular free calcium [1]. The activated enzyme
may generate considerable quantities of a signalling molecule
since it speci¢cally hydrolyses phosphatidylcholine (PC) [2],
the most abundant phospholipid in cell bilayers. Current
models place PLD downstream of the activation of other
e¡ector proteins [1,3], a notion supported by the reported
absence of recognizable signalling domains from its known
sequence structures [4].
The amino acid sequence of two di¡erent mammalian PLDs
have been deduced [4]. Although originally reported to lack
pleckstrin homology (PH) domains [4,5], a recent report in-
dicates the contrary [6]. PLD is stimulated by polyphosphati-
dylinositols [5,7] which is consistent with the presence of a PH
domain [8]. We ¢nd that regions of mammalian PLD1 and
PLD2 show a substantial sequence similarity to the PH do-
main of a recently discovered phosphatidylinositol-3,4,5-tris-
phosphate binding protein (PIP3BP) [9]. Structures of several
PH domains have been solved and are similar despite a lim-
ited amino acid sequence identity [10,11]. A structure-based
hidden Markov model (HMM) built from these solved struc-
tures recognizes the PH domain fold in PLD1 and PLD2. Our
analysis demonstrates that the predicted secondary structure
of the PLD domains includes the seven L-strands and a C-
terminal K-helix characteristic of PH domains as well as ¢ve
conserved amino acids important for interactions with poly-
phosphatidylinositols. In addition, the PLD PH domains in-
clude an unusually large loop between the ¢rst and second L-
strands that may be a unique site of regulation by divalent
cations.
2. Methods
2.1. Assessing homology by pairwise sequence comparison
The recently re¢ned Basic Local Alignment Search Tool (PSI-
BLAST) program [12] was used to compare rat PLD2 to sequences
in the non-redundant database. PSI-BLAST is often sensitive to weak
similarities between proteins that may nonetheless be biologically rel-
evant.
2.2. Assessing homology using family-based models
Family-based HMMs were invoked as an alternative to pairwise
sequence comparisons. A HMM is a statistical model similar to a
sequence pro¢le but may be estimated from unaligned sequences
[13]. HMMs may be based either on the sequence of amino acids
[13] or of secondary structure states [14].
2.3. Sequence-based HMM
A broad collection of PH domain sequences was assembled from
the 41 sequences in the PH domain ‘seed alignment’ from the PFAM
[15] database together with two additional sequences that were iden-
ti¢ed by an independent PSI-BLAST search with PIP3BP as the
query. A HMM was built using the SAM suite version 1.3.1 [13]
with default parameter settings.
2.4. Secondary structure-based HMM
A secondary structure-based HMM was constructed using the
method FORESST [14] from the known secondary structure sequen-
ces of 10 PH domains designated in the SCOP [16] database with the
PDB identi¢ers 1mai, 1btkA, 1bak, 1btn, 1pms, 1mph, 1dro, 1pls,
1dynA and 1awe. The secondary structures of PLD1 and PLD2
were predicted using the prediction methods PredictProtein (PHD)
[17] and Quadratic-Logistic (QL) [18].
2.5. Z-scores
To evaluate the ability of a HMM to recognize its family members,
Z-scores were calculated from log-odds scores [19]. The log-odds
scores were obtained from the ¢t of both PLD domains to the se-
quence-based and secondary structure-based HMMs. The log-odds
score is a measure of how well a given family-based model ¢ts the
query sequence as compared to the ¢t of a ‘null’ model. These scores
were converted to Z-scores which, if the query is not related to the
family, should be distributed as a standard normal (gaussian) varia-
ble, with zero mean and unit S.D.. Accordingly, Z-scores greater than
3.0 are expected to occur no more than 0.13% of the time. Z-scores
are calculated here by subtracting from the query log-odds score the
mean log-odds score for a collection of unrelated proteins (after
length correction) and dividing the result by the S.D. of those scores.
Details of this approach are explored elsewhere [19].
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3. Results and discussion
A pairwise sequence comparison of rat PLD2 with the non-
redundant database using PSI-BLAST [12] reveals similarity
with a 142 amino acid sequence fragment (216^357) of bovine
PIP3BP that includes the sequence (253^355) identi¢ed as its
C-terminal PH domain [9]. The aligning sequence of PLD2
shows 27% sequence identity (29/108 residues) which is con-
sistent with the notion that the two peptides are homologous
[20] although chance alignments with a high identity cannot
be ruled out [21]. The regions of PLD2 and PLD1 that align
with PIP3BP 253^355 have recognizable features of the ¢rst
identi¢ed PH domains including a glycine (G) as one of the
¢rst few amino acids and the nearly invariant tryptophan (W)
in the C-terminal K-helix region [11]. The remaining amino
acids are characteristically rich in large hydrophobic and pos-
itively charged amino acids (Fig. 1).
Because the pairwise sequence alignment between the
PIP3BP PH domain and PLD sequences was relatively
weak, we turned to family-based models to test whether the
aligning regions of PLD1 and 2 are members of the PH do-
main family. By considering the diverse set forming a protein
family, related sequences may be found that are not evident
using pairwise sequence comparison techniques alone. The
two PH domains of PIP3BP and the putative domains of
PLD1 and PLD2 were tested against a sequence-based
HMM. The Z-scores indicate that the two PLD sequences
(Table 1, column 2) are reliably recognized as members of
the PH domain family. Two of the sequences, namely that
of L-adrenergic receptor kinase (L-ARK) and pleckstrin gave
very high Z-scores as expected since they were included in the
training set for the HMM of the PH domain family of pro-
teins.
The secondary structure predictions for the PLD1 and
PLD2 domains were compared against a secondary struc-
ture-based HMM built using FORESST [14]. Z-scores for
the PLD domains were similar in magnitude to those for
the predicted sequence of secondary structure states of the
PH domains of PIP3BP and pleckstrin (Table 1, column 3).
Z-scores of this magnitude or larger would very unlikely occur
by chance (P6 0.002). Interestingly, the secondary structure
prediction for the L-ARK sequence could not be de¢nitively
detected as a PH domain. However, when the nuclear mag-
netic resonance (NMR)-determined secondary structure for L-
ARK [22] was tested against the model, the Z-score increased
to 4.67 (Table 1). This suggests that the failure to recognize L-
ARK as a PH domain was due to a poor quality of predic-
tion, not to a failure of the HMM. Z-scores for the PLD1 and
PLD2 random fragments taken from outside the PH domain
region were not signi¢cant when tested against the sequence-
based or structure-based models. The conclusion that the
PLD sequences are indeed PH domains is also supported by
results from the 3D-1D threading approach of UCLA-DOE
which found classic PH domain proteins with top ranking
scores [23].
The PLC Ls and L-ARK both have PH domains and are
believed to be activated by receptors via interactions with
heterotrimeric G-proteins [24,25]. Structures for the PLC-L
PH domains have not been solved although the solution struc-
FEBS 21834 2-4-99 Cyaan Magenta Geel Zwart
Fig. 1. Alignment of the secondary structure states and amino acid
sequence of putative mammalian PLD1, PLD2 and c. elegans PH
domains with the NMR structure of L-ARK domain [22]. The three
possible secondary structure states are: strand (E), helix (H) and
coil (C). The seven L-strands (in green) and 1 K-helix (red) of L-
ARK (1bak) are indicated as are the corresponding regions of
PLD1 and PLD2. Secondary structure states of the PLD1 and
PLD2 domains were predicted using the PHD method [17]. Se-
quence identities are boxed while sequence similarity together with
sequence identity of L-ARK with either of the PLDs is indicated
with a dot. The ¢ve functionally signi¢cant residues that are con-
served in L-ARK and PLD are indicated in bold.
Table 1
Z-scores for comparison of rPLD1 and rPLD2 to two HMMs of the PH domain family
Protein Z-scores for sequence-based HMM Z-scores for structure-based HMMc
Experimental
rPLD1-PH 2.72 2.94
rPLD2-PH 4.01 3.74
PIP3BP-NPH 8.93 3.17
PIP3BP-CPH 12.08 4.52
Positive controla
Pleck-CPH 25.84 3.35 (5.41)d
L-ARK1-PH 22.46 0.97 (4.67)d
Negative controlb
rPLD1-random 30.14 0.21
rPLD2-random 30.43 31.4
aStructures for the PH domains of Pleck-C and L-ARK have been determined experimentally and are included as positive controls.
bThe random PLD sequences were of the same size as the PH domain but chosen from outside the PH domain region of PLD1 and 2 and are
included as negative controls.
cSecondary structures for the structure-based HMM were predicted from amino acid sequences by the PHD ([17]) method.
dZ-scores for the secondary structure-based HMM of Pleck-C and L-ARK are also provided for their experimentally-derived secondary structure
states. Z-scores greater than 3.0 are expected to occur no more than 0.13% of the time (P6 0.0013).
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ture of the PH domain of L-ARK has been determined by
NMR [22]. Fig. 1 compares the putative PH domains of
PLD1 and PLD2 with that of L-ARK. The predicted sequence
of secondary structure states of the PLD1 and PLD2 domains
approximates the seven L-strands and C-terminal K-helix of
the L-ARK PH domain except that the PHD secondary struc-
ture prediction method [17] did not detect a break between the
putative L2- and L3-strands of the PLD sequences. A di¡erent
secondary structure prediction method, the QL method [18],
did detect a break in this region. The variable loop connecting
the L1- and L2-strands of the putative PLD PH domains is
unusually large and contains the motif H(Xn)CC(Xn)C that
may bind divalent cations like zinc [26] or calcium.
It is striking that many amino acid residues of the PLD
sequences are identical or similar in L-ARK (Fig. 1). The
functional signi¢cance of ¢ve of these residues, G-569, W-
576, R-579, Y-580 and A-596 (Fig. 2), is illustrated by the
fact that they display 15N and 1H spectral perturbations
when the L-ARK PH domain is bound by inositol-1,4,5-tris-
phosphate (IP3) [22]. This is likely to be due to interactions of
positively-charged amino acids in the L1/L2-loop, L2-strand
and L3/L4-loop with negatively charged phosphate groups of
IP3 analogous to PLCN [11,27]. The fact that positively-
charged amino acids, arginine (R) and lysine (K), are also
observed in the putative PLD L1/L2-loop, L2-strand and L3/
L4-loop (Fig. 1) provides a structural basis for the observed
ability of exogenous PIP2 and PIP3 to stimulate the PLD
activity [5,7]. But, since PC is the sole substrate for recep-
tor-activated PLD [2], the possibility exists that the zwitter-
ionic choline-containing headgroup of PC is the physiologi-
cally relevant site recognized by PLD PH domains. The PH
domains of PLDs 1 and 2 are located in the N-terminal third
of the molecule just before the ¢rst of four putative catalytic
regions [28] (Fig. 3).
Previous studies of PLD in permeabilized cells and cell-free
systems have shown that PLD is stimulated by the small
GTP-dependent regulatory protein, ADP-ribosylation factor
(ARF) [5,7,29]. ARF may interact with PLD1 in the region
between its ¢rst and second catalytic regions [30] (Fig. 3). The
above ¢ndings, the reported absence of signalling domains
from PLD and the ability of phorbol esters to stimulate the
enzyme have contributed to the notion that PLD is activated
by receptors in a non-conventional manner that may be
downstream of PLC activation [1,3] and involve small G-pro-
teins like ARF [31] rather than the heterotrimeric G-proteins
or other signalling complexes. The presence of a PH domain
in PLD1 and PLD2 raises the possibility that PLD may also
be regulated by receptors in a more direct manner analogous
to the PLCs involving heterotrimeric G-proteins or kinase
activation [24]. In keeping with regulation by G-proteins, it
is now recognized that a sizable portion of the total genome
of c. elegans is dedicated to signaling through G-protein
coupled receptors [34] and its apparent PLD2 homologic
has a similarly placed domain homologous to the PH domain
of mammalian PLD (Fig. 1). Several targeting mechanisms
have been proposed for PH domains [11] most notably inter-
actions with (1) the anionic phospholipids PIP2 and PIP3, (2)
the LQ-subunit of heterotrimeric G-proteins, (3) protein kinase
C and (4) phosphoserine and phosphothreonine residues of
proteins. Any or all to these mechanisms may target mamma-
lian PLD to membranes when a ligand binds to its receptor.
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